Literature DB >> 7046921

Endogenous hormones as a major factor in human cancer.

B E Henderson, R K Ross, M C Pike, J T Casagrande.   

Abstract

Hormone-related cancers account for almost 30% of all cancer cases in the United States. Data from animal experiments and from epidemiological and endocrinological studies in humans support the hypothesis that the individual hormones which control normal growth of target organs can also create the proper conditions for neoplastic transformation. The concept that hormones can cause, i.e., increase the incidence of, human cancer is most developed for the four hormone-related cancers which are numerically the most important, namely, breast, prostate, endometrium, and ovary. Even for these sites, large gaps remain in our knowledge of the responsible hormones and the conditions which create the optimal opportunity for carcinogenesis. Although scanty, the available epidemiological evidence also suggests a hormonal role in the pathogenesis of testis cancer, thyroid cancer, and osteosarcoma. We believe that the primary prevention of all these cancers will probably depend on modification of the factors which affect the secretion and metabolism of the responsible hormones rather than on control of exposure to classical exogenous initiators.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7046921

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  128 in total

Review 1.  Evidence for decreasing quality of semen during past 50 years.

Authors:  E Carlsen; A Giwercman; N Keiding; N E Skakkebaek
Journal:  BMJ       Date:  1992-09-12

Review 2.  Clinical epidemiology of testicular germ cell tumors.

Authors:  K-P Dieckmann; U Pichlmeier
Journal:  World J Urol       Date:  2004-03-18       Impact factor: 4.226

Review 3.  Energy imbalance and cancer of the breast, colon and prostate.

Authors:  A P Simopoulos
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

Review 4.  Promoter hypermethylation in prostate cancer.

Authors:  Jong Y Park
Journal:  Cancer Control       Date:  2010-10       Impact factor: 3.302

5.  Complementary medicine for prostate cancer: effects of soy and fat consumption.

Authors:  M A Moyad; W A Sakr; D Hirano; G J Miller
Journal:  Rev Urol       Date:  2001

Review 6.  Single nucleotide polymorphisms in DNA repair genes and prostate cancer risk.

Authors:  Jong Y Park; Yifan Huang; Thomas A Sellers
Journal:  Methods Mol Biol       Date:  2009

7.  Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium.

Authors:  Veronica Wendy Setiawan; Jennifer A Doherty; Xiao-Ou Shu; Mohammad R Akbari; Chu Chen; Immaculata De Vivo; Angela Demichele; Montserrat Garcia-Closas; Marc T Goodman; Christopher A Haiman; Susan E Hankinson; Brian E Henderson; Pamela L Horn-Ross; James V Lacey; Loic Le Marchand; Douglas A Levine; Xiaolin Liang; Jolanta Lissowska; Galina Lurie; Monica McGrath; Steven A Narod; Timothy R Rebbeck; Giske Ursin; Noel S Weiss; Yong-Bing Xiang; Hannah P Yang; Wei Zheng; Sara H Olson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01       Impact factor: 4.254

8.  Ames, the Ames test, and the causes of cancer.

Authors:  D Forman
Journal:  BMJ       Date:  1991-08-24

9.  27-hydroxycholesterol is an endogenous selective estrogen receptor modulator.

Authors:  Carolyn D DuSell; Michihisa Umetani; Philip W Shaul; David J Mangelsdorf; Donald P McDonnell
Journal:  Mol Endocrinol       Date:  2007-09-13

10.  Breastfeeding and breast cancer risk.

Authors:  L A Brinton; N A Potischman; C A Swanson; J B Schoenberg; R J Coates; M D Gammon; K E Malone; J L Stanford; J R Daling
Journal:  Cancer Causes Control       Date:  1995-05       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.